A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS

Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?

(2016) Xavier Giffroy et al.   ACTA NEUROLOGICA BELGICA

Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis

(2016) Xavier Giffroy et al.   BMC Neurology

Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems

(2016) Regina Schlaeger et al.   CLINICAL NEUROPHYSIOLOGY

Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy

(2016) R. Iodice et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial

(2016) Rhian Raftopoulos et al.   LANCET NEUROLOGY

Advanced MRI and staging of multiple sclerosis lesions

(2016) Martina Absinta et al.   Nature Reviews Neurology

The contemporary spectrum of multiple sclerosis misdiagnosis

(2016) Andrew J. Solomon et al.   NEUROLOGY

Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis

(2016) Mona Sadeghian et al.   Scientific Reports

Biomarkers in multiple sclerosis

(2015) William J. Housley et al.   CLINICAL IMMUNOLOGY

Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization

(2015) S Amur et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Multimodal neurophysiological evaluation of primary progressive multiple sclerosis – An increasingly valid biomarker, with limits

(2015) L.J.W. Canham et al.   Multiple Sclerosis and Related Disorders

Remyelination Therapy in Multiple Sclerosis

(2015) Danielle E. Harlow et al.   Frontiers in Neurology

Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years

(2014) Regina Schlaeger et al.   Multiple Sclerosis Journal

The visual pathway as a model to understand brain damage in multiple sclerosis

(2014) E H Martínez-Lapiscina et al.   Multiple Sclerosis Journal

Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?

(2014) Giovanni Di Maggio et al.   Multiple Sclerosis Journal

Improved Characterization of Visual Evoked Potentials in Multiple Sclerosis by Topographic Analysis

(2013) Martin Hardmeier et al.   BRAIN TOPOGRAPHY

The utility of multimodal evoked potentials in multiple sclerosis prognostication

(2013) Sudarshini Ramanathan et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Central motor conduction time may predict response to fampridine in patients with multiple sclerosis

(2013) D. Zeller et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis

(2013) Regina Schlaeger et al.   Multiple Sclerosis Journal

Evoked potentials are of little use in the diagnosis or monitoring of MS: Yes

(2013) Christopher McGuigan   Multiple Sclerosis Journal

Evoked potentials are of little use in the diagnosis or monitoring of MS: No

(2013) Oscar Fernández et al.   Multiple Sclerosis Journal

Evoked potentials are of little use in the diagnosis or monitoring of MS: Commentary

(2013) Michael Hutchinson   Multiple Sclerosis Journal

Uhthoff's phenomena in MS—clinical features and pathophysiology

(2013) Teresa C. Frohman et al.   Nature Reviews Neurology

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Demyelination affects temporal aspects of perception: An optic neuritis study

(2011) Noa Raz et al.   ANNALS OF NEUROLOGY

Combined evoked potentials as markers and predictors of disability in early multiple sclerosis

(2011) Regina Schlaeger et al.   CLINICAL NEUROPHYSIOLOGY

Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score

(2011) Paolo Invernizzi et al.   JOURNAL OF NEUROLOGY

Simvastatin improves final visual outcome in acute optic neuritis: a randomized study

(2011) Anna Tsakiri et al.   Multiple Sclerosis Journal

Sensory evoked potentials to predict short-term progression of disability in multiple sclerosis

(2011) N. Margaritella et al.   NEUROLOGICAL SCIENCES

Safety and Feasibility of Autologous Bone Marrow Cellular Therapy in Relapsing-Progressive Multiple Sclerosis

(2010) C M Rice et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Natalizumab restores evoked potential abnormalities in patients with relapsing–remitting multiple sclerosis

(2010) Sven G Meuth et al.   Multiple Sclerosis Journal

Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?

(2009) R. Pelayo et al.   Multiple Sclerosis Journal

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

(2009) Frederik Barkhof et al.   Nature Reviews Neurology

Multimodal evoked potentials measure and predict disability progression in early relapsing–remitting multiple sclerosis

(2008) P Jung et al.   Multiple Sclerosis Journal